Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2009
05/07/2009WO2006047593A3 Method of potentiating inflammatory and immune modulation for cell and drug therapy
05/07/2009WO2006045105A3 Generation and differentiation of adult stem cell lines
05/07/2009WO2006025060A3 Salt responsive genes useful for generating salt resistant transgenic plants
05/07/2009US20090119805 Nuleic acid constructs and methods for producing altered seed oil compositions
05/07/2009US20090119799 nucleic acid molecule encoding an isolated polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium
05/07/2009US20090119798 Barley Row Type Gene and Use Thereof
05/07/2009US20090119797 Gro-1 herbicide resistance gene and methods for its use
05/07/2009US20090119796 Modification of plant lignin content
05/07/2009US20090119795 Delta-9-Elongases and their Use in Making Polyunsaturated Fatty Acids
05/07/2009US20090119793 Plant Defense Signal Peptides
05/07/2009US20090119792 Tomato variety ex01419137
05/07/2009US20090119791 Tobacco cultivar 'aob 175'
05/07/2009US20090119790 Tobacco cultivar 'aob 174'
05/07/2009US20090119789 Tobacco cultivar 'aob 176'
05/07/2009US20090119788 Tobacco cultivar 'aob 171'
05/07/2009US20090118474 Method and composition for crystallizing G protein-coupled receptors
05/07/2009US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines
05/07/2009US20090118468 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines
05/07/2009US20090118377 Apogossypolone and the uses thereof
05/07/2009US20090118362 Chemotherapeutic agents for inhibition of protein translation
05/07/2009US20090118306 Novel use of liver X receptor agonists
05/07/2009US20090118290 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
05/07/2009US20090118244 Benzodiazepinone compounds useful in the treatment of skin conditions
05/07/2009US20090118219 Flea gaba receptor subunit nucleic acid molecules
05/07/2009US20090118212 Methods for producing and using in vivo pseudotyped retroviruses
05/07/2009US20090118210 Epididymal lipocalin gene and uses thereof
05/07/2009US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications
05/07/2009US20090118206 Rna interference for the treatment of gain-of-function disorders
05/07/2009US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
05/07/2009US20090118185 Recombinant factor viii having reduced inactivation by activated protein c
05/07/2009US20090118184 Recombinant factor viii having increased stability
05/07/2009US20090118182 Fibroblast Growth Factor-Like Polypeptides
05/07/2009US20090118166 Conditioned Decellularized Native Tissues for Tissue Restoration
05/07/2009US20090118130 Structure-activity relationships
05/07/2009US20090117657 Preparation For Transferring Nucleic Acid Into Cell
05/07/2009US20090117656 Stimuli-responsive degradable gel
05/07/2009US20090117655 Culture Matrix for Forming a Cell Spheroid, and Method of Culturing the Same
05/07/2009US20090117654 Medium for culturing hematopoietic cells and a method of culturing hematopoietic cells
05/07/2009US20090117653 Method and apparatus for evaluating therapeutics on cancer stem cells
05/07/2009US20090117652 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis
05/07/2009US20090117651 Nucleoside compounds and methods of use thereof
05/07/2009US20090117650 Modified green fluorescent proteins and methods for using same
05/07/2009US20090117641 Mutated Abl Kinase Domains
05/07/2009US20090117639 Neural Progenitor Cell Populations
05/07/2009US20090117627 Process for preparing enantiomerically enriched amines
05/07/2009US20090117618 Expression system for preparing IL-15/FC fusion protein and its use
05/07/2009US20090117615 Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest
05/07/2009US20090117614 degrading mannans and polysaccharides in plant material thus providing a means to recover soluble sugars from these biopolymers
05/07/2009US20090117610 Methods and Compositions for Identifying a Cell Phenotype
05/07/2009US20090117593 T. Cruzi-derived neurotrophic agents and methods of use therefor
05/07/2009US20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof
05/07/2009US20090117585 Anti-fungal screening method
05/07/2009US20090117581 in vitro comprising preparing a cell culture comprising dendritic cells primed with an antigen, then adding syngeneic and allogeneic lymphocytes to the cell culture and measuring the lymphocyte response to the antigen and comparing the response control culture in which the antigen was not used
05/07/2009US20090117577 Methods to identify compounds useful for tumor sensitization to dna damage
05/07/2009US20090117572 Modified cells comprising clostridial toxin substrate for use in diagnosing grampositive bacterial infection; screening for neuroparalytic and botulin syndromes
05/07/2009US20090117564 Estrogen receptor genes and utilization thereof
05/07/2009US20090117563 Identification of TRPML3 (MCOLN3) as a Salty Taste Receptor and Use in Assays for Identifying Taste (Salty) Modulators and/or Therapeutics that Modulate Sodium Transport, Absorption or Excretion and/or Aldosterone and/or Vasopressin Production or Release
05/07/2009US20090117547 NOVEL HAPLOTYPE OF HUMAN T2R RECEPTOR hT2R50 AND ITS USE IN ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS
05/07/2009US20090117545 Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches Cross-Reference to Related Applications
05/07/2009US20090117543 Methods and compositions for inducing sirtuins
05/07/2009US20090117539 DNA sequences for gene suppression
05/07/2009US20090117538 Methods for Obtaining Gene Tags
05/07/2009US20090117175 Hemostatic compositions and therapeutic regimens
05/07/2009US20090117155 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter
05/07/2009US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor
05/07/2009US20090117134 Truncated EGF Receptor
05/07/2009US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS
05/07/2009US20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17
05/07/2009US20090117124 Anti-IgE antibodies
05/07/2009US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427
05/07/2009US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization
05/07/2009US20090117117 Targeting abcb5 for cancer therapy
05/07/2009US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer
05/07/2009US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof
05/07/2009US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus
05/07/2009US20090117096 Methods and compositions for inhibition of metastasis
05/07/2009US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
05/07/2009US20090117086 Preparation of replicating macrophages and use in diagnosis and therapy
05/07/2009US20090117085 Mntf differentiation and growth of stem cells
05/07/2009US20090117084 Bacteriophage and prophage proteins in cancer gene therapy
05/07/2009US20090117057 Grape Polyphenolics for Platelet and Bacterial Control
05/07/2009US20090117043 Antibodies That Specifically Bind to Neurokinin B
05/07/2009US20090117036 Antibodies against gpr64 and uses thereof
05/07/2009US20090117032 Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque
05/07/2009US20090117031 Methods for Treating Glioma
05/07/2009CA2714777A1 Methods for co-culturing cord blood derived cells with menstrual stem cells
05/07/2009CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs
05/06/2009EP2056111A1 Methods and compositions for regulating protein-protein interactions
05/06/2009EP2055779A2 Auxin transport proteins
05/06/2009EP2055772A1 Method for inhibiting the development of teratoma
05/06/2009EP2055713A1 Peptide purification by means of metal ion affinity chromatography
05/06/2009EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue
05/06/2009EP2054512A2 Pullulanase variants with increased productivity
05/06/2009EP2054508A2 Tumor suppression using placental stem cells
05/06/2009EP2054507A1 Method of production of transgenic avian using embryonic stem cells
05/06/2009EP2054506A1 Mesenchymal stem cell conditioned medium
05/06/2009EP2054504A2 Retinoid compounds and their use
05/06/2009EP2054444A2 Antibodies to erbb2
05/06/2009EP2054437A2 Albumin-insulin fusion proteins
05/06/2009EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth)